v2.4.0.8
Stockholders' Equity (Tables)
36 Months Ended
Dec. 31, 2013
Equity [Abstract]  
Summary of Option Activity

A summary of option activity under all of the above plans for the year ended December 31, 2013 is as follows (shares and aggregate intrinsic value in thousands):

 

     Shares     Wtd. Avg.
Exercise Price
     Wtd. Avg.
Remaining
Contractual Life
     Aggregate
Intrinsic
Value
 

Outstanding at December 31, 2012

     643      $ 0.90         

Granted during fiscal year 2013

     275      $ 0.73         

Expired during fiscal year 2013

     (25   $ 5.44         

Forfeited during fiscal year 2013

     —             
  

 

 

         

Outstanding at December 31, 2013

     893      $ 0.72         4.76 years       $ 741   
  

 

 

         

Vested and expected to vest

     861      $ 0.72         4.63 years       $ 715   
  

 

 

         

Exercisable at December 31, 2013

     617      $ 0.71         3.79 years       $ 519   
  

 

 

         
Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options at December 31, 2013, and changes during the year then ended are presented below (shares in thousands):

 

     Shares     Weighted-average
grant-date  fair value
 

Non-vested at December 31, 2012

     139      $ 0.50   

Granted

     275      $ 0.58   

Vested

     (138   $ 0.49   

Forfeited

              
  

 

 

   

Non-vested at December 31, 2013

     276      $ 0.58   
Summary of Share-Based Compensation Expense

The following table summarizes share-based compensation expense for the years ended December 31 (in thousands):

 

     2013      2012      2011  

Selling, general and administrative:

        

Non-employee directors

   $ 11       $ 18       $ 10   

Officers

     40         63         39   

Others

     18         28         24   
  

 

 

    

 

 

    

 

 

 

Total SG&A

     69         109         73   

Research and development

     40         122         122   
  

 

 

    

 

 

    

 

 

 

Total share-based compensation expense before taxes

     109         231         195   

Related deferred income tax benefits

                       
  

 

 

    

 

 

    

 

 

 

Share-based compensation expense

   $ 109       $ 231       $ 195